Is a preoperative pathogen detection a prerequisite before undergoing one-stage exchange for prosthetic joint infection of the hip?
Culture negative
One-stage exchange
PJI
Pathogen detection
Journal
Archives of orthopaedic and trauma surgery
ISSN: 1434-3916
Titre abrégé: Arch Orthop Trauma Surg
Pays: Germany
ID NLM: 9011043
Informations de publication
Date de publication:
Jun 2023
Jun 2023
Historique:
received:
31
12
2021
accepted:
16
04
2022
medline:
19
5
2023
pubmed:
5
5
2022
entrez:
4
5
2022
Statut:
ppublish
Résumé
A preoperative pathogen detection is considered a prerequisite before undergoing one-stage exchange for prosthetic joint infection (PJI) according to most guidelines. This study compares patients with and without preoperative pathogen detection undergoing one-stage exchange for PJI of the hip. The authors put up the hypothesis that a preoperative pathogen detection is no prerequisite in selected cases undergoing one-stage exchange. 30 consecutive patients with PJI of the hip, treated with one-stage exchange, between 2011 and 2021, were retrospectively included. Mean age was 70 years and mean follow-up 2.1 ± 1.8 years. PJI was defined according to the European Bone and Joint Infection Society. One-stage exchange was performed in (1) chronic PJI longer than 4 weeks, (2) well-retained bone condition, (3) absence of multiple prior revisions for PJI (≤ 2) with absence of difficult-to-treat pathogens in the past, and (4) necessity/preference for early mobility due to comorbidities/age. One-stage exchange was performed in 20 patients with and in 10 without a preoperative pathogen detection. Age (71 years, 68 years, p = 0.519), sex (50% and 30% males, p = 0.440), American Society of Anesthesiologists Score (2.2, 2.4, p = 0.502), and Charlson Comorbidity Index (3, 4, p = 0.530) did not differ among the two groups. No significant differences were noted concerning preoperative CRP (15 mg/l, 43 mg/l, p = 0.228), synovial cell count (15.990/nl, 5.308/nl, p = 0.887), radiological signs of loosening (55%, 50%, p = 0.999), and intraoperative histopathology. Except a higher rate of coagulase-negative staphylococci (70%, 20%, p = 0.019) in patients with a preoperative pathogen detection, no significant differences in pathogen spectrum were identified among groups. Revision for PJI recurrence was performed in one patient with an initial preoperative pathogen detection (3.3%). Additional revisions were performed for dislocation in two and postoperative hematoma in one patient. Revision rate for both septic and aseptic causes (p = 0.999), stay in hospital (16 and 15 days, p = 0.373) and modified Harris Hip Score (60, 71, p = 0.350) did not differ between groups. Patients with and without a preoperative pathogen detection did not show significant differences concerning baseline characteristics, clinical and functional outcomes at 2 years. An absent preoperative pathogen detection is no absolute contraindication for one-stage exchange in chronic PJI, if involving good bone quality and absence of multiple prior revisions.
Sections du résumé
BACKGROUND
BACKGROUND
A preoperative pathogen detection is considered a prerequisite before undergoing one-stage exchange for prosthetic joint infection (PJI) according to most guidelines. This study compares patients with and without preoperative pathogen detection undergoing one-stage exchange for PJI of the hip. The authors put up the hypothesis that a preoperative pathogen detection is no prerequisite in selected cases undergoing one-stage exchange.
METHODS
METHODS
30 consecutive patients with PJI of the hip, treated with one-stage exchange, between 2011 and 2021, were retrospectively included. Mean age was 70 years and mean follow-up 2.1 ± 1.8 years. PJI was defined according to the European Bone and Joint Infection Society. One-stage exchange was performed in (1) chronic PJI longer than 4 weeks, (2) well-retained bone condition, (3) absence of multiple prior revisions for PJI (≤ 2) with absence of difficult-to-treat pathogens in the past, and (4) necessity/preference for early mobility due to comorbidities/age.
RESULTS
RESULTS
One-stage exchange was performed in 20 patients with and in 10 without a preoperative pathogen detection. Age (71 years, 68 years, p = 0.519), sex (50% and 30% males, p = 0.440), American Society of Anesthesiologists Score (2.2, 2.4, p = 0.502), and Charlson Comorbidity Index (3, 4, p = 0.530) did not differ among the two groups. No significant differences were noted concerning preoperative CRP (15 mg/l, 43 mg/l, p = 0.228), synovial cell count (15.990/nl, 5.308/nl, p = 0.887), radiological signs of loosening (55%, 50%, p = 0.999), and intraoperative histopathology. Except a higher rate of coagulase-negative staphylococci (70%, 20%, p = 0.019) in patients with a preoperative pathogen detection, no significant differences in pathogen spectrum were identified among groups. Revision for PJI recurrence was performed in one patient with an initial preoperative pathogen detection (3.3%). Additional revisions were performed for dislocation in two and postoperative hematoma in one patient. Revision rate for both septic and aseptic causes (p = 0.999), stay in hospital (16 and 15 days, p = 0.373) and modified Harris Hip Score (60, 71, p = 0.350) did not differ between groups.
CONCLUSION
CONCLUSIONS
Patients with and without a preoperative pathogen detection did not show significant differences concerning baseline characteristics, clinical and functional outcomes at 2 years. An absent preoperative pathogen detection is no absolute contraindication for one-stage exchange in chronic PJI, if involving good bone quality and absence of multiple prior revisions.
Identifiants
pubmed: 35508548
doi: 10.1007/s00402-022-04459-5
pii: 10.1007/s00402-022-04459-5
pmc: PMC10191905
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2823-2830Informations de copyright
© 2022. The Author(s).
Références
J Arthroplasty. 2021 May;36(5):1758-1764
pubmed: 33267978
Bone Joint J. 2019 Jan;101-B(1_Supple_A):19-24
pubmed: 30648487
N Engl J Med. 2004 Oct 14;351(16):1645-54
pubmed: 15483283
Bone Joint J. 2021 Mar;103-B(3):515-521
pubmed: 33455434
Clin Infect Dis. 2013 Jan;56(1):1-10
pubmed: 23230301
Bone Joint J. 2021 Jan;103-B(1):18-25
pubmed: 33380199
J Arthroplasty. 2018 May;33(5):1309-1314.e2
pubmed: 29551303
Clin Orthop Relat Res. 2015 Jan;473(1):8-14
pubmed: 24923669
Int Orthop. 2016 May;40(5):913-8
pubmed: 26224611
Int Orthop. 2018 May;42(5):983-994
pubmed: 29523955
Hip Pelvis. 2018 Sep;30(3):138-146
pubmed: 30202747
Bone Joint J. 2013 Nov;95-B(11 Suppl A):77-83
pubmed: 24187359
BMC Musculoskelet Disord. 2021 Sep 12;22(1):780
pubmed: 34511107
J Arthroplasty. 2013 Sep;28(8 Suppl):66-70
pubmed: 23972299
Bone Joint J. 2014 Apr;96-B(4):492-6
pubmed: 24692616
J Arthroplasty. 2018 Apr;33(4):1160-1165.e1
pubmed: 29221839
Expert Rev Med Devices. 2020 Mar;17(3):245-252
pubmed: 32098518
Orthop Traumatol Surg Res. 2016 Feb;102(1):127-9
pubmed: 26611716
Arch Orthop Trauma Surg. 2018 May;138(5):635-642
pubmed: 29352435
J Arthroplasty. 2014 May;29(5):1076-81
pubmed: 24332970
Curr Rev Musculoskelet Med. 2018 Sep;11(3):370-379
pubmed: 29987643
Clin Orthop Relat Res. 2013 Jul;471(7):2374-82
pubmed: 23440616
Clin Orthop Relat Res. 2022 May 1;480(5):905-914
pubmed: 34851871
J Bone Joint Surg Am. 2011 Apr 6;93(7):631-9
pubmed: 21471416
J Orthop Res. 2014 Jan;32 Suppl 1:S141-6
pubmed: 24464888
PLoS One. 2015 Sep 25;10(9):e0139166
pubmed: 26407003
J Arthroplasty. 2017 Sep;32(9S):S59-S62
pubmed: 28302460
Clin Microbiol Rev. 2014 Apr;27(2):302-45
pubmed: 24696437
EFORT Open Rev. 2019 Jul 29;4(7):482-494
pubmed: 31423332
Int Orthop. 2022 Mar;46(3):449-456
pubmed: 34783888
Pathol Res Pract. 2014 Dec;210(12):779-86
pubmed: 25454771
Bone Joint J. 2019 Apr;101-B(4):396-402
pubmed: 30929477
Orthop Traumatol Surg Res. 2021 Jun;107(4):102668
pubmed: 32798125